Inventurus Knowledge Solutions Limited — Investor Meet, 22-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

IKS Health has announced a board meeting on the financial results for the quarter and half-year.

IKS showed strong Q4 FY25 with 17% YoY revenue growth to INR724 Cr, EBITDA up 68% at INR226 Cr, and PAT surging 133%, driven by margin expansion to ~31%. FY25 revenue increased 47% YoY to INR2,664 Cr, EBITDA nearly 50% to INR791 Cr, and PAT rose 31% despite higher finance costs from the AQuity acquisition. The strategic focus is on evolving AI-enabled platforms, margin optimization, and expanding wallet share, especially with mid-size and PE-backed clients. Operationally, employee count fell reflecting a tech-led shift. Management highlights strong cash flow (INR434 Cr), reduced net debt, and a growing sales pipeline. Market consolidation and platform scale provide moat amid rising competition.